Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

DzMab-1: Anti-Human Diacylglycerol Kinaseζ Monoclonal Antibody for Immunocytochemistry.

Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Sano M, Sayama Y, Yamada S, Kaneko MK, Kato Y, Goto K.

Monoclon Antib Immunodiagn Immunother. 2019 Aug;38(4):179-182. doi: 10.1089/mab.2019.0024.

PMID:
31403910
2.

DgMab-6: Antihuman DGKγ Monoclonal Antibody for Immunocytochemistry.

Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Yamaki A, Sakane F, Shirai Y, Nakamura T, Yanaka M, Yamada S, Kaneko MK, Kato Y, Goto K.

Monoclon Antib Immunodiagn Immunother. 2018 Nov;37(5):229-232. doi: 10.1089/mab.2018.0026.

PMID:
30362931
3.

DaMab-2: Anti-Human DGKα Monoclonal Antibody for Immunocytochemistry.

Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Mizuno S, Satoh E, Sakane F, Okada N, Taketomi A, Honma R, Nakamura T, Saidoh N, Yanaka M, Itai S, Handa S, Chang YW, Yamada S, Kaneko MK, Kato Y, Goto K.

Monoclon Antib Immunodiagn Immunother. 2017 Aug;36(4):181-184. doi: 10.1089/mab.2017.0023. Epub 2017 Jul 25.

PMID:
28742439
4.

Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.

Ogasawara S, Oki H, Kaneko MK, Hozumi Y, Liu X, Honma R, Fujii Y, Nakamura T, Goto K, Takagi M, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2015 Oct;34(5):318-26. doi: 10.1089/mab.2015.0018.

PMID:
26492619
5.

Monoclonal Antibody LpMab-9 Recognizes O-glycosylated N-Terminus of Human Podoplanin.

Kaneko MK, Oki H, Hozumi Y, Liu X, Ogasawara S, Takagi M, Goto K, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2015 Oct;34(5):310-7. doi: 10.1089/mab.2015.0022.

PMID:
26492618
6.

A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.

Liu X, Ogasawara S, Kaneko MK, Oki H, Hozumi Y, Goto K, Takagi M, Kato Y.

Biochem Biophys Res Commun. 2015 Apr 17;459(4):636-42. doi: 10.1016/j.bbrc.2015.02.162. Epub 2015 Mar 6.

PMID:
25753205
7.

Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations.

Kaneko MK, Tsujimoto Y, Hozumi Y, Goto K, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2013 Jun;32(3):224-8. doi: 10.1089/mab.2013.0006.

PMID:
23750482
8.

Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.

Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K, Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y.

Biochem Biophys Res Commun. 2013 Mar 1;432(1):40-5. doi: 10.1016/j.bbrc.2013.01.088. Epub 2013 Jan 31.

PMID:
23376717
9.

Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity.

Kaneko MK, Kunita A, Abe S, Tsujimoto Y, Fukayama M, Goto K, Sawa Y, Nishioka Y, Kato Y.

Cancer Sci. 2012 Nov;103(11):1913-9. doi: 10.1111/j.1349-7006.2012.02385.x. Epub 2012 Aug 27.

10.

Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.

Kaneko MK, Tian W, Takano S, Suzuki H, Sawa Y, Hozumi Y, Goto K, Yamazaki K, Kitanaka C, Kato Y.

Biochem Biophys Res Commun. 2011 Mar 25;406(4):608-13. doi: 10.1016/j.bbrc.2011.02.102. Epub 2011 Feb 23.

PMID:
21352804

Supplemental Content

Loading ...
Support Center